drugset / Trial / NCT01024335

Dronabinol Naltrexone Treatment for Opioid Dependence

NCT01024335

RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this two-year study is to test the efficacy of dronabinol as an adjunct to maintenance treatment with naltrexone in opioid-dependent individuals. We hypothesize that administering dronabinol during detoxification and during the first few weeks of naltrexone treatment will lead to improved naltrexone tolerability, resulting in better naltrexone compliance and treatment retention, and ultimately a reduction in opioid use and relapse rates.

Timeline

Start
2010-01
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified 15 mg
Background Naltrexone Small molecule 380 mg Other

Indications